Answers are grounded in this paper and cite their sources.
Review highlights severe nocturnal hypoxia and elevated cardiovascular risks in overlap syndrome, indicating the critical need for prompt clinical evaluation and targeted therapy.
The overlap syndrome (OS) was first coined by David C. Flenley in 1985 to describe the coexistence of obstructive sleep apnea (OSA) in patients with chronic obstructive pulmonary disease (COPD). Patients with OS experience more profound nocturnal oxygen desaturation (NOD) than patients with OSA or COPD alone. This underlying hypoxia in OS increases the risk of cardiovascular disease including atrial fibrillation, right heart failure, and pulmonary hypertension, thereby increasing the mortality associated with the disease. Keeping in mind the risk of mortality, it is crucial for clinicians to clinically evaluate the patients with OSA or COPD for the occurrence of OS and provide effective treatment options for the same. This review aims to highlight the pathophysiology and the risks associated with the OS along with early detection and appropriate management protocols to reduce the mortality associated with it.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: